| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Solomons Neil82 | Chief Medical Officer | Sale+OE | 150,000 | $19.84 | $2,976,000.00 | -52.2% | +5.4% | -63.5% | |
| Sep 7, 2021 | Martin Michael Robert82 | Chief Business Officer | Sell | 7,500 | $18.10 | $135,750.00 | -4.1% | +5.5% | -63.3% | |
| Sep 7, 2021 | Huizinga Robert Bindert77 | EVP Of Research | Sell | 5,000 | $18.30 | $91,500.00 | -3.5% | +5.5% | -63.3% | |
| Aug 26, 2021 | Martin Michael Robert82 | Chief Business Officer | Sell | 22,500 | $17.81 | $400,725.00 | -10.9% | +9.9% | -56.9% | |
| Aug 25, 2021 | Solomons Neil82 | Chief Medical Officer | Sell | 5,000 | $15.85 | $79,250.00 | -3.5% | +17.8% | -51.3% | |
| Aug 9, 2021 | Solomons Neil82 | Chief Medical Officer | Sell | 45,000 | $16.03 | $721,350.00 | -24.0% | +99.6% | -48.2% | |
| Aug 9, 2021 | Martin Michael Robert82 | Chief Business Officer | Sell | 5,000 | $16.01 | $80,050.00 | -2.4% | +99.6% | -48.2% | |
| Jul 28, 2021 | Martin Michael Robert82 | Chief Business Officer | Sell | 5,000 | $13.86 | $69,300.00 | -2.3% | +113.1% | -41.6% | |
| Jun 22, 2021 | Martin Michael Robert82 | Chief Business Officer | Sell | 5,000 | $13.76 | $68,800.00 | -2.3% | +49.3% | -20.4% | |
| May 12, 2021 | MacKay-Dunn R. Hector47 | Director | Buy | 4,500 | $11.23 | $50,529.00 | +41.3% | +35.0% | -12.4% |